Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group (Q40687779)

22 September 2017

Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group (English)

1 reference

22 September 2017

1

Fosså SD

1 reference

22 September 2017

Droz JP

2

1 reference

22 September 2017

Stoter G

3

1 reference

22 September 2017

Kaye SB

4

1 reference

22 September 2017

Vermeylen K

5

1 reference

22 September 2017

Sylvester R

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 March 1995

1 reference

British Journal of Cancer

22 September 2017

1 reference

22 September 2017

71

1 reference

22 September 2017

3

1 reference

22 September 2017

619-624

1 reference

Postorchiectomy radiotherapy for stages I and II testicular seminoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033625

Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033625

Treatment of the Residual Retroperitoneal Mass After Chemotherapy for Advanced Seminoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033625

Therapeutic guidelines and results in advanced seminoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033625

Pulmonary toxicity of cytotoxic and immunosuppressive agents. A review

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033625

Combined management of malignant teratoma of the testis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033625

Radiotherapy as initial treatment for bulky stage II testicular seminomas.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033625

Radiotherapy for stage 2 testicular seminoma: the prognostic influence of tumor bulk

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033625

Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033625

The treatment of advanced seminoma with chemotherapy and radiotherapy

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033625

Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033625

The treatment of advanced metastatic seminoma: experience in 55 cases

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033625

Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy

19 August 2018

1 reference

12 December 2020

Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience

1 reference

12 December 2020

Advanced seminoma: the role of chemotherapy and adjunctive surgery

1 reference

12 December 2020

A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors

1 reference

12 December 2020

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

1 reference

12 December 2020

Combination chemotherapy with vinblastine, ifosfamide and cisplatin in bulky seminoma

1 reference

12 December 2020

Modern radiotherapy results with bulky stages II and III seminoma

1 reference

12 December 2020

The activity of single-agent carboplatin in advanced seminoma

1 reference

12 December 2020

Single-agent carboplatinum for advanced seminoma. A phase II study

1 reference

12 December 2020

Seminoma of the testis: results of treatment and patterns of failure after radiation therapy

1 reference

12 December 2020

The management of metastatic seminoma testis

1 reference

12 December 2020

The management of advanced seminoma

1 reference

12 December 2020

The chemotherapy of metastatic seminoma

1 reference

12 December 2020

Cisplatin combination chemotherapy in advanced seminoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.121

1 reference

Dimensions Publication ID

22 September 2017

0 references

1 reference

22 September 2017

PubMed publication ID

7880748

1 reference